Trypsin-Induced Phospholipase Activity in Human Platelets
By WALTER C. PICKETT, ROBERT L. JESSE and PHIN COHEN Department ofNutrition, Harvard School ofPublic Health, Boston, MA 02115, U.S.A. (Received 23 August 1976) Trypsin mediates a release of arachidonic acid with resultant increase in 02 consumption (a reflection of cyclo-oxygenase activity) by whole human platelets that is similar to thrombin's effect on these cells. The trypsin and thrombin effects can be differentiated in two ways: (1) at saturating concentrations the measured effects of trypsin greatly exceed those of thrombin; (2) EGTA [ethanedioxybis(etbylamine)-NNN'N'-tetra-acetate] augments the effect of thrombin but not of trypsin. Thus trypsin and thrombin probably act at different loci in the pathway that induces phospholipase activity in human platelets.
We recently showed that the thrombin-mediated burst in 02 consumption by human platelets is secondary to release and subsequent oxygenation of arachidonic acid (Pickett & Cohen, 1976a) . Using the same techniques, we now present evidence that trypsin induces the release of arachidonic acid and the consumption of 02, thus closely mimicking the effects of thrombin. The importance of this observation is that addition of trypsin might simulate the mechanism by which thrombin brings into play the activities of phospholipase A2 (EC3.1.1.4) and, by extension, cyclo-oxygenase of human platelets.
Experimental
Methods previously described were used to prepare platelet homogenates and membranes (Broekman etal., 1974) , iso-osmotic (Pickett & Cohen, 1976a ) and hypo-osmotic (Pickett & Cohen, 1976b) suspensions, and to measure the consumption of 02 and release of fatty acids in an 02-depleted reaction mixture (Pickett & Cohen, 1976a) .; In some studies platelets were lysed by sonication, three cycles of freeze-thawing, severe osmotic shock or exposure to detergents.
Incubation mixtures were at pH7.4 and most often at 300mosM, and contained, in a volume of 1. . In studies where the release of arachidonic acid was measured, the reaction mixture was made anaerobic as described by Pickett & Cohen (1976a) . Thrombin (Ortho Pharmaceuticals, Raritan, NJ, U.S.A.) was added to the incubations, as described by Pickett & Cohen (1976a) . Trypsin (Sigma Chemical Vol. 160 Co., St. Louis, MO, U.S.A.) unless otherwise indicated was added to give a concentration of 222,g per incubation, the remaining proteinases (Sigma) to give concentrations of 600,ug per incubation.
Results
At the concentrations used, EGTA prevented the marked platelet-aggregating effects of thrombin. Trypsin-treated platelets did not aggregate macroscopically, or, if already spontaneously aggregated, were partially redispersed on the addition of trypsin, which at a concentration of 222,ug per incubation caused obvious platelet lysis. Spontaneous aggregation occurred only in the absence of EGTA and did not, in the absence of thrombin, affect 02 consumption. In the presence of thrombin, marked aggregation, even to the point of producing a tight ball of platelets, did not affect the completeness of the extraction of lipids in general, or of fatty acids in particular. Fig. 1 shows that the effect of trypsin on 02 consumption by human platelets was similar in onset and duration to that of thrombin. At concentrations that stimulated maximal initial rates of 02 consumption the effect of trypsin was twice that of thrombin (Fig. 2) . In parallel experiments to those shown in Fig. 2 , in the absence of EGTA four times as much unesterified arachidonic acid was recovered after adding trypsin as after adding thrombin. In the presence of EGTA, the stimulation by thrombin of arachidonic acid release was augmented 2.5-fold, whereas the trypsin-induced response was unaffected (Table 1) . Addition of CaCl2 did not increase the release of arachidonic acid produced by the addition of thrombin or trypsin.
The specific effect of trypsin, among proteolytic agents, was shown when additions of ac-chymotrypsin, pepsin, bacterial proteinases (IV, V, VI), bromelin, ficin or papain were shown to have no effect on arachidonic acid release or on 02 consumption. As we reported in studies with addition of arachidonate or thrombin (Pickett & Cohen, 1976a) , the effects of trypsin were sensitive to acetylsalicylic acid but not to cyanide. Platelet homogenates or membranes, or whole platelets that were exposed to sonication, freeze-thawing, osmotic shock or detergents, over a wide range of pH and Ca2+ concentrations (Derksen & Cohen, 1975) were less than 10% as responsive to thrombin or to trypsin as measured by release of arachidonic acid or the stimulation of 02 consumption.
Discsson
Phospholipase activity ofpig pancreas is augmented by storage, even at 4°C. de Haas et al. (1968) were the first to show that tryptic digestion converts pancreatic pro-phospholipase into the active phospholipase. Duchesne et al. (1972) found in studies with rats that the phospholipase activity of platelet-poor plasma is unmasked by crude trypsin as well as by clotting. This led Duchesne et aL (1972) to suggest that a substance in platelets, themselves weak in phospholipase activity, has a proteolytic action that mimics the effect of trypsin. The present results suggest that the phospholipase activity induced by trypsin in suspensions of human platelets would, by analogy with the studies on pancreas (de Haas et al., 1968) , appear to result from tryptic modification of a pro-phospholipase in the platelets themselves. The locus of such a pro-phospholipase is likely to be in the membranes, which represent the subcellular fraction with the greatest concentration of both substrate and active enzyme (Derksen & Cohen, 1975) . However, compared with intact platelets, disrupted platelets showed a markedly smaller response to added trypsin (or to thrombin). Yet homogenates or membranes can oxygenate added arachidonic acid, and platelets in 80mosm media contain mitochondria that show tightly coupled respiration (Pickett & Cohen, 1976b) . Thus it would appear that the structural integrity of the platelet or the co-operation ofa non-membranous component, or both, are indispensable to the abilities of trypsin or thrombin to induce the phospholipase activity that furnishes unesterified arachidonic acid. Except for EGTA, all-chemical and physical agents that were tried either abolished or did not affect the actions of trypsin and thrombin that we have studied.
That EGTA was able to augment the effect of thrombin but not that of trypsin suggests that each of these compounds influences a different point in the pathway that initiates phospholipase activity.
In earlier studies we found that phospholipase A2 activity ofhuman platelet membrane preparations, in keeping with that from other sources, has an absolute requirement for Ca2+ (Derksen & Cohen, 1975) . Subsequently, we showed that thrombin induced phospholipase activity in intact platelets that had been washed and resuspended in Ca2+-free buffer and then exposed to 5mM-EGTA (Pickett & Cohen, 1976a) . In the present work with the intact platelet, EGTA was apparently able to enhance the effect of thrombin on phospholipase A2 activity without enhancing its own access to the Ca2+ which is an essential cofactor for the phospholipase. This (b) trypsin in the presence ofEGTA (5mM) Each incubation mixture contained 5mg of platelet protein in a volume of 1.8ml. For other details, see the Experimental section. Each point is the mean for three experiments, each in duplicate. At the concentrations used to obtain the results shown in Fig. 1 , both compounds were maximally active and the stimulatory effect of trypsin was twice that of thrombin. platelet shape (Zucker & Borelli, 1954) or volume (Bull & Zucker, 1965) , and in so doing facilitates binding of thrombin to the platelet surface (Tollefsen et al., 1973) . Such an effect, in turn, could have enhanced the ability of thrombin to induce proteolysis or the release reaction (Tollefsen et al., 1973) , either of which could affect phospholipase activity in a way that is at present unknown. Attention Vol, 160 is drawn to a facilitating role for an intracellular component, which is perhaps mobilized by the release reaction, since thrombin and trypsin were much more effective in stimulating the release of arachidonic acid in whole platelets than in membranes. Trypsin, which is unlike thrombin in that it has no specific receptor sites on human platelets (Tollefsen et al., 1973) , seemed able to activate phospholipase A2 activity equally well in the presence or absence of EGTA. Our data are insufficient to say whether the trypsin effect was specific at concentrations that caused the maximum release of arachidonic acid. The proteolytic attack by trypsin was severe enough to cause platelet lysis, which, in a non-specific manner, could have activated phospholipase A2. However, disruption of platelets by sonication, freeze-thawing, detergents or osmotic shock failed to produce the same effect. Thus a specific effect of trypsin on the phospholipase A2 complex cannot be ruled out. Such an effect could derive from cleavage of a pro-phospholipase or removal of barrier molecules that normally isolate the phospholipase from activating influences elsewhere in the cell.
We conclude that, compared with thrombin, trypsin is a more powerful stimulator of human platelet phospholipase activity. The effect ofthrombin on platelet phospholipase activity may be mediated by the release of a trypsin-like intracellular proteinase that leads to activation of a membrane-bound pro-phospholipase. This work was supported by Grant HL13802 from the U.S. Public Health Service and by Contract DADA-17-70-C-0083 from the U.S. Army. Platelet suspensions were derived from blood that was drawn from normal donors (Blood Bank, Peter Bent Brigham Hospital) or from volunteers who underwent a two-unit plasmapheresis (Blood Bank, Massachusetts General Hospital). Ms. Laura Varnum, R.N., did the plasmaphereses.
